News - SYN120

Filter

Current filters:

SYN120

Popular Filters

Biotie assets available for partnering; update on tozadenant

08-07-2012

Finland-based biotech firm Biotie Therapies' (OMX: BTH1V) retention of SYN120 rights after Roche decided…

BiotechnologyBiotie TherapiesFinancialLicensingLundbeckNeurologicalResearchSelincroSYN120tozadenantUCB

Roche returns rights to Biotie Therapies SYN120

27-06-2012

Finland-based Biotie Therapies (OMX: BTH1V) said yesterday that it is retaining global development and…

Biotie TherapiesLicensingNeurologicalPharmaceuticalRocheSYN120

Back to top